RARE Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Ultragenyx Pharmaceutical Inc (RARE) Moving Averages Convergence Divergence (MACD) indicator is 0.736, suggesting RARE is Sell.

Ultragenyx Pharmaceutical Inc (RARE) 20-Day simple moving average is 25.136, while Ultragenyx Pharmaceutical Inc (RARE) share price is $24.33, making it Sell.

Ultragenyx Pharmaceutical Inc (RARE) 60-Day simple moving average is 23.095, while Ultragenyx Pharmaceutical Inc (RARE) share price is $24.33, making it Buy.

Technical Analysis for RARE

Technical Sentiment Analysis for Ultragenyx Pharmaceutical Inc (RARE) As of 2026-05-15, Ultragenyx Pharmaceutical Inc (RARE) is exhibiting a Sell technical sentiment. Our proprietary analysis, which aggregates 10 technical signals, shows that 4 indicators are flashing buy, while 6 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for RARE stands at 51.71, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.736, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 55.134 and the Commodity Channel Index (CCI) at 6.375 further confirm a 0.23 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, RARE is trading below its 60-day moving average of $23.095 and below its 200-day long-term moving average of $27.656. Key price levels to watch include the immediate resistance at $27.43 and strong support at $24.24. A break above $27.43 could signal a bull continuation, while falling below $24.24 may test the next Fibonacci floor at $22.64.

Ultragenyx Pharmaceutical Inc (RARE) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	21.05	22.64	24.24	25.83	27.43	29.02	30.62
Fibonacci	22.64	23.859	24.611	25.83	27.049	27.801	29.02

Ultragenyx Pharmaceutical Inc (RARE) Technical Indicators

2026-05-15

Name	Value
RSI_14	51.71
STOCHk_14_3_3	55.134
STOCHd_14_3_3	67.699
CCI_20	6.375
AO_5_34	2.004
MOM_10	0.23
MACD_12_26_9	0.736

Ultragenyx Pharmaceutical Inc (RARE) Relative Strength Index (RSI) is 51.71, creating a Neutral signal.

Ultragenyx Pharmaceutical Inc (RARE) Stochastic Oscillator is 55.134, creating a Neutral signal.

Ultragenyx Pharmaceutical Inc (RARE) Stochastic RSI is 67.699, creating a Neutral signal.

Ultragenyx Pharmaceutical Inc (RARE) Commodity Channel Index (CCI) is 6.375, creating a Neutral signal.

Ultragenyx Pharmaceutical Inc (RARE) Awesome Oscillator is 2.004, creating a Buy signal.

Ultragenyx Pharmaceutical Inc (RARE) Momentum is 0.23, creating a Buy signal.

Ultragenyx Pharmaceutical Inc (RARE) MACD is 0.736, creating a Buy signal.

Ultragenyx Pharmaceutical Inc (RARE) Moving Average

2026-05-15

Period	Simple	Signal
MA_5	26.08	Sell
MA_10	25.84	Sell
MA_20	25.136	Sell
MA_60	23.095	Buy
MA_200	27.656	Sell
MA_250	28.974	Sell

Ultragenyx Pharmaceutical Inc (RARE) 5-Day simple moving average is 26.08, while Ultragenyx Pharmaceutical Inc (RARE) share price is $24.33, making it a Sell.

Ultragenyx Pharmaceutical Inc (RARE) 10-Day simple moving average is 25.84, while Ultragenyx Pharmaceutical Inc (RARE) share price is $24.33, making it a Sell.

Ultragenyx Pharmaceutical Inc (RARE) 20-Day simple moving average is 25.136, while Ultragenyx Pharmaceutical Inc (RARE) share price is $24.33, making it a Sell.

Ultragenyx Pharmaceutical Inc (RARE) 60-Day simple moving average is 23.095, while Ultragenyx Pharmaceutical Inc (RARE) share price is $24.33, making it a Buy.

Ultragenyx Pharmaceutical Inc (RARE) 200-Day simple moving average is 27.656, while Ultragenyx Pharmaceutical Inc (RARE) share price is $24.33, making it a Sell.

Ultragenyx Pharmaceutical Inc (RARE) 250-Day simple moving average is 28.974, while Ultragenyx Pharmaceutical Inc (RARE) share price is $24.33, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for RARE?

The overall technical consensus for Ultragenyx Pharmaceutical Inc (RARE) is currently Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 1 sell signals.

What are the key support and resistance levels for Ultragenyx Pharmaceutical Inc (RARE) today?

Based on pivot point calculations, Ultragenyx Pharmaceutical Inc (RARE) has an immediate support level at 24.24 and a major resistance level at 27.43. Traders also monitor the pivot point at 25.83 to determine the intraday trend direction.

Is Ultragenyx Pharmaceutical Inc (RARE) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Ultragenyx Pharmaceutical Inc (RARE) is currently 51.71. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Ultragenyx Pharmaceutical Inc (RARE)?

Ultragenyx Pharmaceutical Inc (RARE) Moving Averages Convergence Divergence (MACD) indicator is 0.736, suggesting RARE is Sell. This indicator helps identify potential trend reversals or momentum shifts for Ultragenyx Pharmaceutical Inc.

How is Ultragenyx Pharmaceutical Inc (RARE) performing relative to its 200-day moving average?

Ultragenyx Pharmaceutical Inc (RARE) is currently trading at $24.33, which is below its 200-day simple moving average of 27.656. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.